Ion channels and myogenic activity in retinal arterioles.

Retinal pressure autoregulation is an important mechanism that protects the retina by stabilizing retinal blood flow during changes in arterial or intraocular pressure. Similar to other vascular beds, retinal pressure autoregulation is thought to be mediated largely through the myogenic response of small arteries and arterioles which constrict when transmural pressure increases or dilate when it decreases.

Over recent years, we and others have investigated the signaling pathways underlying the myogenic response in retinal arterioles, with particular emphasis on the involvement of different ion channels expressed in the smooth muscle layer of these vessels.

Here, we review and extend previous work on the expression and spatial distribution of the plasma membrane and sarcoplasmic reticulum ion channels present in retinal vascular smooth muscle cells (VSMCs) and discuss their contribution to pressure-induced myogenic tone in retinal arterioles.

This includes new data demonstrating that several key players and modulators of the myogenic response show distinctively heterogeneous expression along the length of the retinal arteriolar network, suggesting differences in myogenic signaling between larger and smaller pre-capillary arterioles.

PEG5-Ms
573027 500.0mg
EUR 360

PEG4-Ms
HY-140388 Get quote Ask for price
Description: PEG4-Ms is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs[1].

PEG4-Ms
T16459-10mg 10mg Ask for price
Description: PEG4-Ms

PEG4-Ms
T16459-1g 1g Ask for price
Description: PEG4-Ms

PEG4-Ms
T16459-1mg 1mg Ask for price
Description: PEG4-Ms

PEG4-Ms
T16459-50mg 50mg Ask for price
Description: PEG4-Ms

PEG4-Ms
T16459-5mg 5mg Ask for price
Description: PEG4-Ms

PEG-MGF
A002-02 2 mg Ask for price

4-Arm PEG-MA
abx085177-10kDa1g 10 kDa; 1 g
EUR 610.8

4-Arm PEG-MA
abx085177-20kDa1g 20 kDa; 1 g
EUR 610.8

4-Arm PEG-MA
abx085177-20kDa5g 20 kDa; 5 g
EUR 1228.8

4-Arm PEG-MA
abx085177-5kDa1g 5 kDa; 1 g
EUR 577.2

N-(m-PEG4)-N'-(PEG3-Mal)-Cy5
HY-141076 Get quote Ask for price
Description: N-(m-PEG4)-N'-(PEG3-Mal)-Cy5 is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs[1].

N-(m-PEG4)-N'-(PEG3-Mal)-Cy5
T18435-10mg 10mg Ask for price
Description: N-(m-PEG4)-N'-(PEG3-Mal)-Cy5

N-(m-PEG4)-N'-(PEG3-Mal)-Cy5
T18435-1g 1g Ask for price
Description: N-(m-PEG4)-N'-(PEG3-Mal)-Cy5

N-(m-PEG4)-N'-(PEG3-Mal)-Cy5
T18435-1mg 1mg Ask for price
Description: N-(m-PEG4)-N'-(PEG3-Mal)-Cy5

N-(m-PEG4)-N'-(PEG3-Mal)-Cy5
T18435-50mg 50mg Ask for price
Description: N-(m-PEG4)-N'-(PEG3-Mal)-Cy5

N-(m-PEG4)-N'-(PEG3-Mal)-Cy5
T18435-5mg 5mg Ask for price
Description: N-(m-PEG4)-N'-(PEG3-Mal)-Cy5

4-Arm PEG-Mal
abx085089-100l 100 µl
EUR 300

4-Arm PEG-Mal
abx085089-10kDa1g 10 kDa; 1 g
EUR 477.6

4-Arm PEG-Mal
abx085089-1ml 1 ml
EUR 312.5

4-Arm PEG-Mal
abx085089-200l 200 µl
EUR 312.5

4-Arm PEG-Mal
abx085089-20kDa1g 20 kDa; 1 g
EUR 477.6

4-Arm PEG-Mal
abx085089-20kDa5g 20 kDa; 5 g
EUR 844.8

4-Arm PEG-Mal
abx085089-5kDa1g 5 kDa; 1 g
EUR 444

8-Arm PEG-Mal
abx085119-100l 100 µl
EUR 300

8-Arm PEG-Mal
abx085119-10kDa1g 10 kDa; 1 g
EUR 444

8-Arm PEG-Mal
abx085119-1ml 1 ml
EUR 300

8-Arm PEG-Mal
abx085119-200l 200 µl
EUR 300

8-Arm PEG-Mal
abx085119-20kDa1g 20 kDa; 1 g
EUR 444

8-Arm PEG-Mal
abx085119-20kDa5g 20 kDa; 5 g
EUR 961.2

8-Arm PEG-Mal
abx085119-40kDa1g 40 kDa; 1 g
EUR 444

Cy3.5-PEG-Mal
abx085322-100l 100 µl
EUR 662.5

Cy3.5-PEG-Mal
abx085322-10kDa500mg 10 kDa; 500 mg
EUR 961.2

Cy3.5-PEG-Mal
abx085322-1ml 1 ml
EUR 662.5

Cy3.5-PEG-Mal
abx085322-200l 200 µl
EUR 662.5

Cy3.5-PEG-Mal
abx085322-2kDa500mg 2 kDa; 500 mg
EUR 961.2

Cy3.5-PEG-Mal
abx085322-34kDa500mg 3.4 kDa; 500 mg
EUR 961.2

Cy3.5-PEG-Mal
abx085322-5kDa500mg 5 kDa; 500 mg
EUR 961.2

PCL(12K)-PEG-Mal
abx085326-10kDa500mg 10 kDa; 500 mg
EUR 1144.8

PCL(12K)-PEG-Mal
abx085326-2kDa500mg 2 kDa; 500 mg
EUR 1144.8

PCL(12K)-PEG-Mal
abx085326-5kDa500mg 5 kDa; 500 mg
EUR 1144.8

PLGA(5K)-PEG-Mal
abx085332-34kDa500mg 3.4 kDa; 500 mg
EUR 1245.6

PLGA(50:50)(8K)-PEG-Mal
abx085344-05kDa500mg 0.5 kDa; 500 mg
EUR 1296

PLGA(50:50)(8K)-PEG-Mal
abx085344-1kDa500mg 1 kDa; 500 mg
EUR 1446

PLGA(50:50)(8K)-PEG-Mal
abx085344-2kDa500mg 2 kDa; 500 mg
EUR 1479.6

PLGA(50:50)(8K)-PEG-Mal
abx085344-34kDa500mg 3.4 kDa; 500 mg
EUR 1479.6

PCL(12K)-PEG-Mal,2K
HE062022-2K-500mg 500mg
EUR 800.4
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound.

PCL(12K)-PEG-Mal,5K
HE062022-5K-500mg 500mg
EUR 800.4
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound.

PLGA(5K)-PEG-MAL,2K
HE085022-2K-500mg 500mg
EUR 873.6
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound.

PLGA(5K)-PEG-MAL,3.4K
HE085022-3.4K-500mg 500mg
EUR 873.6
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound.

PLGA(5K)-PEG-MAL,5K
HE085022-5K-500mg 500mg
EUR 873.6
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound.

PLGA(50:50)?8K?-PEG-Mal,1K
HE086022-1K-500mg 500mg
EUR 800.4
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound.

PLGA(50:50)?8K?-PEG-Mal,2K
HE086022-2K-500mg 500mg
EUR 770.4
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound.

PLGA(50:50)?8K?-PEG-Mal,3.4K
HE086022-3.4K-500mg 500mg
EUR 770.4
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound.

PLGA(50:50)?8K?-PEG-Mal,500
HE086022-500-500mg 500mg
EUR 918
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound.

PLGA(50:50)?8K?-PEG-Mal,5K
HE086022-5K-500mg 500mg
EUR 770.4
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound.

Cy3.5-PEG-Mal,2K
FL077022-2K-500mg 500mg
EUR 652.8
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound.

Cy3.5-PEG-Mal,3.4K
FL077022-3.4K-500mg 500mg
EUR 652.8
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound.

Cy3.5-PEG-Mal,5K
FL077022-5K-500mg 500mg
EUR 652.8
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound.

PLGA(30K)-PEG-Mal
abx085340-100l 100 µl
EUR 625

PLGA(30K)-PEG-Mal
abx085340-1ml 1 ml Ask for price

PLGA(30K)-PEG-Mal
abx085340-200l 200 µl
EUR 1025

PCL(12K)-PEG-Mal,10K
HE062022-10K-500mg 500mg
EUR 800.4
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound.

PCL(12K)-PEG-Mal,20K
HE062022-20K-500mg 500mg
EUR 800.4
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound.

PLGA(12K)-PEG-MAL,2K
33-HE088022-2K
  • Ask for price
  • Ask for price
  • 100MG
  • 500MG
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound.

PLGA(12K)-PEG-MAL,3.4K
33-HE088022-3.4K
  • Ask for price
  • Ask for price
  • 100MG
  • 500MG
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound.

PLGA(12K)-PEG-MAL,5K
33-HE088022-5K
  • Ask for price
  • Ask for price
  • 100MG
  • 500MG
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound.

PLGA(18K)-PEG-MAL,3.4K
33-HE118022-3.4K
  • Ask for price
  • Ask for price
  • 100mg
  • 500mg
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound.

Cy3.5-PEG-Mal,10K
FL077022-10K-500mg 500mg
EUR 652.8
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound.

Cy3.5-PEG-Mal,20K
FL077022-20K-500mg 500mg
EUR 652.8
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound.

Anti MGF PEG-MGF Pab
165657 100 µg Ask for price

PEG3-methylamine
HY-140161 100 mg
EUR 54.11
Description: PEG3-methylamine is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs[1].

PEG3-methylamine
T16457-10mg 10mg Ask for price
Description: PEG3-methylamine

PEG3-methylamine
T16457-1g 1g Ask for price
Description: PEG3-methylamine

PEG3-methylamine
T16457-1mg 1mg Ask for price
Description: PEG3-methylamine

PEG3-methylamine
T16457-50mg 50mg Ask for price
Description: PEG3-methylamine

PEG3-methylamine
T16457-5mg 5mg Ask for price
Description: PEG3-methylamine

PEG8000-MgCl2 Solution (40%, Sterilized)
G0562
  • Ask for price
  • Ask for price
  • 100 mL
  • 500 mL

Anti-TACSTD2 (clone 7E6)-PEG6-MMAD ADC
ADC-W-292 1mg Ask for price
Description: This ADC product is comprised of an anti-TACSTD2 monoclonal antibody (clone 7E6) conjugated via a PEG6 linker to MMAD

Anti-TACSTD2 (clone C16)-PEG6-MMAD ADC
ADC-W-538 1mg Ask for price
Description: This ADC product is comprised of an anti-TACSTD2 monoclonal antibody (clone C16) conjugated via a PEG6 linker to MMAD

4-Arm PEG-Methacrylate
abx085177-100l 100 µl
EUR 362.5

4-Arm PEG-Methacrylate
abx085177-1ml 1 ml
EUR 362.5

4-Arm PEG-Methacrylate
abx085177-200l 200 µl
EUR 362.5

Anti-MUC1 (clone huC242)-PEG4Mal-DM1 ADC
ADC-W-313 1mg Ask for price
Description: This ADC product is comprised of an anti-MUC1 monoclonal antibody (clone huC242) conjugated via a PEG4Mal linker to a DM1

Anti-TNFRSF17 (clone 2A1)-PEG4-Mal-DM4 ADC
ADC-W-121 1mg Ask for price
Description: This ADC product is comprised of an anti-TNFRSF17 monoclonal antibody (clone 2A1) conjugated via a PEG4-Mal linker to DM4

Anti-TNFRSF17 (clone 1E1)-PEG4-Mal-DM4 ADC
ADC-W-125 1mg Ask for price
Description: This ADC product is comprised of an anti-TNFRSF17 monoclonal antibody (clone 1E1) conjugated via a PEG4-Mal linker to DM4

16.67% PEG / 3.33M NaCl solution
IBS-BP073 1L
EUR 56

N-(Propargyl-PEG4-carbonyl)-N-bis(PEG1-methyl ester)
HY-140095 100 mg
EUR 216.45
Description: N-(Propargyl-PEG4-carbonyl)-N-bis(PEG1-methyl ester) is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs[1]. N-(Propargyl-PEG4-carbonyl)-N-bis(PEG1-methyl ester) is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.

N-(Propargyl-PEG4-carbonyl)-N-bis(PEG1-methyl ester)
T16248-10mg 10mg Ask for price
Description: N-(Propargyl-PEG4-carbonyl)-N-bis(PEG1-methyl ester)

N-(Propargyl-PEG4-carbonyl)-N-bis(PEG1-methyl ester)
T16248-1g 1g Ask for price
Description: N-(Propargyl-PEG4-carbonyl)-N-bis(PEG1-methyl ester)

N-(Propargyl-PEG4-carbonyl)-N-bis(PEG1-methyl ester)
T16248-1mg 1mg Ask for price
Description: N-(Propargyl-PEG4-carbonyl)-N-bis(PEG1-methyl ester)

N-(Propargyl-PEG4-carbonyl)-N-bis(PEG1-methyl ester)
T16248-50mg 50mg Ask for price
Description: N-(Propargyl-PEG4-carbonyl)-N-bis(PEG1-methyl ester)

N-(Propargyl-PEG4-carbonyl)-N-bis(PEG1-methyl ester)
T16248-5mg 5mg Ask for price
Description: N-(Propargyl-PEG4-carbonyl)-N-bis(PEG1-methyl ester)

PEG-modified Au Nanorods (Absorption Peak 690-850 nm)
NM005020 10 mL Ask for price

Polyethylene glycol monomethacrylate (PEGMA 440)
24890-100 100g
EUR 71.28
Description: 25736-86-1

Polyethylene glycol monomethacrylate (PEGMA 440)
24890-1000 1kg
EUR 396.36
Description: 25736-86-1

Polyethylene glycol monomethacrylate (PEGMA 200)
16712-100 100g
EUR 86.4
Description: 25736-86-1

Polyethylene glycol monomethacrylate (PEGMA 400)
16713-100 100g
EUR 75.6
Description: 25736-86-1

18:1 PEG1000 PE
HY-155932 Get quote Ask for price
Description: 18:1 PEG1000 PE is a PEG lipid functional end group used in the synthesis of liposomes (LPs) for the design of conjugated polymer nanoparticles. Through biotin modification and carboxyl terminus, lipid nanoparticles (LNPs) further coupling with other biomolecules can be achieved. Functionalized nanoparticles can be used for targeted labeling of specific cellular proteins. With streptavidin as a linker, biotinylated PEG lipid-conjugated polymer nanoparticles are able to bind to biotinylated antibodies on cell surface receptors, yielding the utility of fluorescence-based imaging and sensing.

18:1 PEG3000 PE
HY-155933 Get quote Ask for price
Description: 18:1 PEG3000 PE is a PEG lipid functional end group used in the synthesis of liposomes (LPs) for the design of conjugated polymer nanoparticles. Through biotin modification and carboxyl terminus, lipid nanoparticles (LNPs) further coupling with other biomolecules can be achieved. Functionalized nanoparticles can be used for targeted labeling of specific cellular proteins. With streptavidin as a linker, biotinylated PEG lipid-conjugated polymer nanoparticles are able to bind to biotinylated antibodies on cell surface receptors, yielding the utility of fluorescence-based imaging and sensing.

18:1 PEG5000 PE
HY-155934 Get quote Ask for price
Description: 18:1 PEG5000 PE is a PEG lipid functional end group used in the synthesis of liposomes (LPs) for the design of conjugated polymer nanoparticles. Through biotin modification and carboxyl terminus, lipid nanoparticles (LNPs) further coupling with other biomolecules can be achieved. Functionalized nanoparticles can be used for targeted labeling of specific cellular proteins. With streptavidin as a linker, biotinylated PEG lipid-conjugated polymer nanoparticles are able to bind to biotinylated antibodies on cell surface receptors, yielding the utility of fluorescence-based imaging and sensing.

18:1 PEG2000 PE
HY-144010 Get quote Ask for price
Description: 18:1 PEG2000 PE (18:1 PEG-PE) is a polyethyleneglycol/phosphatidyl-ethanolamine conjugate. 18:1 PEG2000 PE can be used for drug delivery[1].

18:1 PEG350 PE
HY-155930 Get quote Ask for price
Description: 18:1 PEG350 PE is a PEG lipid functional end group used in the synthesis of liposomes (LPs) for the design of conjugated polymer nanoparticles. Through biotin modification and carboxyl terminus, lipid nanoparticles (LNPs) further coupling with other biomolecules can be achieved. Functionalized nanoparticles can be used for targeted labeling of specific cellular proteins. With streptavidin as a linker, biotinylated PEG lipid-conjugated polymer nanoparticles are able to bind to biotinylated antibodies on cell surface receptors, yielding the utility of fluorescence-based imaging and sensing.

18:1 PEG550 PE
HY-155931 Get quote Ask for price
Description: 18:1 PEG550 PE is a PEG lipid functional end group used in the synthesis of liposomes (LPs) for the design of conjugated polymer nanoparticles. Through biotin modification and carboxyl terminus, lipid nanoparticles (LNPs) further coupling with other biomolecules can be achieved. Functionalized nanoparticles can be used for targeted labeling of specific cellular proteins. With streptavidin as a linker, biotinylated PEG lipid-conjugated polymer nanoparticles are able to bind to biotinylated antibodies on cell surface receptors, yielding the utility of fluorescence-based imaging and sensing.

AzoDye-1 PEG10 Alkyne
2415-1mg 1 mg
EUR 151
Description: AzoDye-1 PEG10 alkyne is an excellent building block for labeling azide-containing molecules.

PEG3-tetrazine, 1 g
1978-1g 1 g
EUR 793.2

DBCO PEG13 NHS 1 µmol scale
26-6746-01 1 Each Ask for price

AzoDye-1 PEG10 Succinimidyl Ester
2403-5mg 5 mg
EUR 97
Description: AzoDye-1 PEG10 Succinimidyl Ester is an excellent building block for labeling amino-containing molecules.

pEGFP-1
PVTY00993 2ug
EUR 280

JBScreen Membrane 1 (PEG 400 to PEG 2000 MME based)
M-CS-301L 24 solutions
EUR 414
Description: JBScreen Membrane 1 (PEG 400 to PEG 2000 MME based)

PEG3 dicarboxylic acid, 1 g
1715-1g 1 g
EUR 423.6

pEGFP- MD2- 1
PVT10180 2 ug
EUR 361.2

DBCO PEG4 NHS 1 µmol scale
26-6745-01 1 Each Ask for price

Azide PEG4 NHS 1 µmol scale
26-6754-01 1 Each Ask for price

Lenti ORF clone of Peg10 (mGFP-tagged) - Mouse paternally expressed 10 (Peg10), transcript variant 1, encoding isoform 1
MR224445L4 10 µg Ask for price

Alkyne PEG4 NHS 1 µmol scale
26-6752-01 1 Each Ask for price

JBScreen Classic 1 (PEG 400 to 3000 based)
M-CS-101L 24 solutions
EUR 249
Description: JBScreen Classic 1 (PEG 400 to 3000 based)

Peg12 sgRNA CRISPR Lentivector (Rat) (Target 1)
K6370802 1.0 ug DNA
EUR 184.8

PEG30K-Cys-AEEAc-Fibrinopeptide A (1-15)
4066201.05 0.5 mg
EUR 240.45

PEG30K-Cys-AEEAc-Fibrinopeptide A (1-15)
4066201.1 1 mg
EUR 422.42

PEG30K-Cys-AEEAc-Fibrinopeptide A (1-15)
H-8348.0500 0.5mg
EUR 410.4
Description: Sum Formula: C66H101N17O29S+PEG30K

PEG30K-Cys-AEEAc-Fibrinopeptide A (1-15)
H-8348.1000 1.0mg
EUR 691.2
Description: Sum Formula: C66H101N17O29S+PEG30K

PEG10 sgRNA CRISPR Lentivector (Human) (Target 1)
K1626702 1.0 ug DNA
EUR 184.8

Peg12 sgRNA CRISPR Lentivector (Mouse) (Target 1)
K3769502 1.0 ug DNA
EUR 184.8

Peg10 sgRNA CRISPR Lentivector (Mouse) (Target 1)
K4676402 1.0 ug DNA
EUR 184.8

pEGFP- 1 Plasmid
PVT1201 2 ug
EUR 319.2

PEG10 (untagged)-Human paternally expressed 10 (PEG10), transcript variant 1
SC108513 10 µg Ask for price

PEG10 (untagged)-Human paternally expressed 10 (PEG10) transcript variant 1
SC328573 10 µg Ask for price

PEG10 (untagged)-Human paternally expressed 10 (PEG10), transcript variant 1
SC318188 10 µg Ask for price

PEG10 (untagged)-Human paternally expressed 10 (PEG10), transcript variant 1
SC324334 10 µg Ask for price

Lenti ORF clone of Peg10 (Myc-DDK-tagged) - Mouse paternally expressed 10 (Peg10), transcript variant 1, encoding isoform 1
MR224445L3 10 µg Ask for price

Biotin PEG2 amine *CAS 138529-46-1*
3014-5mg 5 mg
EUR 109
Description: This carbonyl-reactive biotin derivative contains a long arm (~20 angstrom) increase its avidin-binding affinity.

Azide PEG3 Maleimide 1 µmol scale
26-6761-01 1 Each Ask for price

Peg10 (untagged) - Mouse paternally expressed 10 (Peg10), transcript variant 1, (10ug)
MC223182 10 µg Ask for price

PEG10 (GFP-tagged) - Human paternally expressed 10 (PEG10), transcript variant 1
RG208683 10 µg Ask for price

PEG10 (GFP-tagged) - Human paternally expressed 10 (PEG10), transcript variant 1
RG229935 10 µg Ask for price

PEG10 (GFP-tagged) - Human paternally expressed 10 (PEG10), transcript variant 1
RG231501 10 µg Ask for price

PEG10 (GFP-tagged) - Human paternally expressed 10 (PEG10), transcript variant 1
RG223371 10 µg Ask for price

Lenti ORF particles, Peg10 (GFP-tagged) - Mouse paternally expressed 10 (Peg10), transcript variant 1, encoding isoform 1, 200ul, >10^7 TU/mL
MR224445L4V 200 µl Ask for price

Peg10 (GFP-tagged) - Mouse paternally expressed 10 (Peg10) transcript variant 1, (10ug)
MG224445 10 µg Ask for price

Peg10 (GFP-tagged) - Mouse paternally expressed 10 (Peg10) transcript variant 1, (10ug)
MG225144 10 µg Ask for price

Peg10 (Myc-DDK-tagged) - Mouse paternally expressed 10 (Peg10), transcript variant 1
MR224445 10 µg Ask for price

Peg10 (Myc-DDK-tagged) - Mouse paternally expressed 10 (Peg10), transcript variant 1
MR225144 10 µg Ask for price

PEG10 (Myc-DDK-tagged)-Human paternally expressed 10 (PEG10), transcript variant 1
RC231501 10 µg Ask for price

PEG10 (Myc-DDK-tagged)-Human paternally expressed 10 (PEG10), transcript variant 1
RC229935 10 µg Ask for price

PEG10 (Myc-DDK-tagged)-Human paternally expressed 10 (PEG10), transcript variant 1
RC223371 10 µg Ask for price

PEG10 (Myc-DDK-tagged)-Human paternally expressed 10 (PEG10), transcript variant 1
RC208683 10 µg Ask for price

JBScreen PEG/Salt 1
CS-141 24solutions
EUR 198.63

JBScreen PEG/Salt 1
M-CS-141 24 solutions
EUR 263
Description: JBScreen PEG/Salt 1

pEGFP-C1-LMP-1
PPL80108-2a 1149bp
EUR 218
Description: pEGFP-C1

pEGFP-C3-Bif-1
PPL00333-2a 1098bp
EUR 218
Description: pEGFP-C3

Lenti ORF particles, Peg10 (Myc-DDK-tagged) - Mouse paternally expressed 10 (Peg10), transcript variant 1, encoding isoform 1, 200ul, >10^7 TU/mL
MR224445L3V 200 µl Ask for price

PEG3 (untagged)-Human paternally expressed 3 (PEG3), transcript variant 1
SC128281 10 µg Ask for price

PEG3 sgRNA CRISPR Lentivector (Human) (Target 1)
K1626502 1.0 ug DNA
EUR 184.8

Peg3 sgRNA CRISPR Lentivector (Mouse) (Target 1)
K4341802 1.0 ug DNA
EUR 184.8

pEGFP-N1-Caspase 1
PPL00392-2e 1212bp
EUR 218
Description: pEGFP-N1

Halo Chloro Tag C6 PEG4 NHS 1 µmol scale
26-6455-01 1 Each Ask for price

PEG3AS sgRNA CRISPR Lentivector (Human) (Target 1)
K1626602 1.0 ug DNA
EUR 184.8

PEG3 (GFP-tagged) - Human paternally expressed 3 (PEG3), transcript variant 1
RG215328 10 µg Ask for price

iFluor®488-PEG12-dUTP *1 mM in Tris Buffer (pH 7.5)*
17041 25 nmoles
EUR 101
Description: The dye-modified deoxyuridine 5'-triphosphates are one of the most common methods to produce dye-labelled DNA via the conventional enzymatic incorporation methods such as reverse transcription, nick translation, random primed labeling, or PCR.

iFluor®488-PEG12-dUTP *1 mM in Tris Buffer (pH 7.5)*
17041-25nmoles 25 nmoles
EUR 99
Description: The dye-modified deoxyuridine 5'-triphosphates are one of the most common methods to produce dye-labelled DNA via the conventional enzymatic incorporation methods such as reverse transcription, nick translation, random primed labeling, or PCR.

iFluor®555-PEG12-dUTP *1 mM in Tris Buffer (pH 7.5)*
17042 25 nmoles
EUR 101
Description: The dye-modified deoxyuridine 5'-triphosphates are one of the most common methods to produce dye-labelled DNA via the conventional enzymatic incorporation methods such as reverse transcription, nick translation, random primed labeling, or PCR.

iFluor®555-PEG12-dUTP *1 mM in Tris Buffer (pH 7.5)*
17042-25nmoles 25 nmoles
EUR 99
Description: The dye-modified deoxyuridine 5'-triphosphates are one of the most common methods to produce dye-labelled DNA via the conventional enzymatic incorporation methods such as reverse transcription, nick translation, random primed labeling, or PCR.

iFluor®647-PEG12-dUTP *1 mM in Tris Buffer (pH 7.5)*
17043 25 nmoles
EUR 101
Description: The dye-modified deoxyuridine 5'-triphosphates are one of the most common methods to produce dye-labeled DNA via conventional enzymatic incorporation methods such as reverse transcription, nick translation, random primed labeling, or PCR.

iFluor®647-PEG12-dUTP *1 mM in Tris Buffer (pH 7.5)*
17043-25nmoles 25 nmoles
EUR 99
Description: The dye-modified deoxyuridine 5'-triphosphates are one of the most common methods to produce dye-labelled DNA via the conventional enzymatic incorporation methods such as reverse transcription, nick translation, random primed labeling, or PCR.

JBScreen PEG/Salt 1 - 4
CS-145 4Kits
EUR 670.49

JBScreen PEG/Salt 1 - 4
M-CS-145 4 Kits
EUR 858
Description: JBScreen PEG/Salt 1 - 4

pEGFP-Gsdmd-m(1-976)
PVT22039 2ug
EUR 280

pEGFP-C1-TYR-c-1
PVT20226 2ug
EUR 280

Our immunohistochemical investigations have also highlighted the presence of actin-containing microstructures called myobridges that connect the retinal VSMCs to one another. Although further work is still needed, studies to date investigating myogenic mechanisms in the retina have contributed to a better understanding of how blood flow is regulated in this tissue. They also provide a basis to direct future research into retinal diseases where blood flow changes contribute to the pathology.